Compare $ASMB vs $CAPR | Chartloom

Compare

$ASMB vs $CAPR

Assembly Biosciences Inc · Capricor Therapeutics Inc

ASMB

Assembly Biosciences Inc

CAPR

Capricor Therapeutics Inc

Compare $ASMB vs $CAPR

Comparing Assembly Biosciences Inc and Capricor Therapeutics Inc

ASMBAssembly Biosciences Inc

CAPRCapricor Therapeutics Inc

ASMBAssembly Biosciences Inc

Market cap

$466M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.93x

Rev growth (TTM)

125.1%

YTD performance

-30.3%

52W performance

-7.7%

FCF yield

-8.3%

CAPRCapricor Therapeutics Inc

Market cap

$453M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.84x

Rev growth (TTM)

-100.0%

YTD performance

-72.3%

52W performance

4.4%

FCF yield

-28.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ASMB

CAPR

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

CAPR

Capricor Therapeutics Inc

Market Cap

ASMB$466M

CAPR$453M

Enterprise Value

ASMB$434M

CAPR$433M

Price

ASMB$23.53

CAPR$7.83

P/E Ratio

ASMBN/A

CAPRN/A

P/S Ratio

ASMB6.23x

CAPR23.36x

EV/Sales

ASMB5.80x

CAPR22.42x

EV/EBITDA

ASMB0.00x

CAPR1,019.20x

P/B Ratio

ASMB1.50x

CAPR2.11x

P/FCF Ratio

ASMBN/A

CAPRN/A

EV/FCF

ASMB-11.26x

CAPR-3.33x

PEG Ratio

ASMBN/A

CAPRN/A

Forward P/E (NTM)

ASMBN/A

CAPRN/A

Forward P/S (NTM)

ASMB17.93x

CAPR6.84x

Revenue (TTM)

ASMB$75M

CAPR$0

Revenue Growth (YoY)

ASMB125.1%

CAPR-100.0%

Forward Rev Growth

ASMB2.1%

CAPR-27.8%

Gross Margin (TTM)

ASMB0.0%

CAPR0.0%

Operating Margin (TTM)

ASMB0.0%

CAPR0.0%

EBITDA Margin (TTM)

ASMB-11.6%

CAPR0.0%

Net Margin (TTM)

ASMB-0.1%

CAPR0.0%

FCF Margin (TTM)

ASMB-51.5%

CAPRN/A

Net Income (TTM)

ASMB$-42K

CAPR$-129M

FCF (TTM)

ASMB$-39M

CAPR$-130M

EPS (TTM)

ASMB-$0.00

CAPR-$2.23

ROE (TTM)

ASMB-2.0%

CAPR-5660.0%

ROA (TTM)

ASMB-2.0%

CAPR-4397.0%

ROIC (TTM)

ASMB-2.0%

CAPR-5562.0%

Cash

ASMB$32M

CAPR$21M

Debt

ASMB$0

CAPR$0

Net Cash/Debt

ASMB$32M

CAPR$21M

Current Ratio (TTM)

ASMB13.99x

CAPR7.35x

Quick Ratio (TTM)

ASMB13.70x

CAPR7.22x

Debt/Equity (TTM)

ASMB0.00x

CAPR0.02x

Debt/Assets (TTM)

ASMB0.0%

CAPR0.0%

Interest Coverage (TTM)

ASMBN/A

CAPRN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

CAPR0.00x

Beta

ASMB1.21

CAPR0.59

52W Performance

ASMB-7.7%

CAPR4.4%

YTD Performance

ASMB-30.3%

CAPR-72.3%

% from 52W High

ASMB-40.7%

CAPR-80.6%

% from 52W Low

ASMB8.0%

CAPR164.5%

Asset Turnover (TTM)

ASMB0.28x

CAPR0.25x

FCF Yield (TTM)

ASMB-8.3%

CAPR-28.6%

Earnings Yield (TTM)

ASMB-0.0%

CAPR-28.5%

Dividend Yield (TTM)

ASMBN/A

CAPRN/A

Rule of 40

ASMB73.6

CAPR-100.0

EV/GP/RG

ASMBN/A

CAPRN/A

Ticker research

View ASMB research View CAPR research

Metric	ASMB Assembly Biosciences Inc	CAPR Capricor Therapeutics Inc
Market & Valuation
Market Cap	$466M	$453M
Enterprise Value	$434M	$433M
Price	$23.53	$7.83
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	23.36x
EV/Sales	5.80x	22.42x
EV/EBITDA	0.00x	1,019.20x
P/B Ratio	1.50x	2.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-3.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	6.84x
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	-100.0%
Forward Rev Growth	2.1%	-27.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-129M
FCF (TTM)	$-39M	$-130M
EPS (TTM)	-$0.00	-$2.23
ROE (TTM)	-2.0%	-5660.0%
ROA (TTM)	-2.0%	-4397.0%
ROIC (TTM)	-2.0%	-5562.0%
Financial Health
Cash	$32M	$21M
Debt	$0	$0
Net Cash/Debt	$32M	$21M
Current Ratio (TTM)	13.99x	7.35x
Quick Ratio (TTM)	13.70x	7.22x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.59
52W Performance	-7.7%	4.4%
YTD Performance	-30.3%	-72.3%
% from 52W High	-40.7%	-80.6%
% from 52W Low	8.0%	164.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.25x
FCF Yield (TTM)	-8.3%	-28.6%
Earnings Yield (TTM)	-0.0%	-28.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View CAPR research

Valuation

P/S Ratio

ASMB

6.23x

CAPR

23.36x

EV/FCF

ASMB

-11.26x

CAPR

-3.33x

Growth & revenue

Revenue Growth TTM

ASMB

125.1%

CAPR

-100.0%

Forward Revenue Growth

ASMB

2.1%

CAPR

-27.8%

Profitability & performance

Gross Margin

ASMB

0.0%

CAPR

0.0%

ROE

ASMB

-2.0%

CAPR

-5660.0%

FCF Yield %

ASMB

-8.3%

CAPR

-28.6%

52-Week Performance

CAPR

4.4%

ASMB

-7.7%

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

CAPR

Capricor Therapeutics Inc

Market Cap

ASMB$466M

CAPR$453M

Enterprise Value

ASMB$434M

CAPR$433M

Price

ASMB$23.53

CAPR$7.83

P/E Ratio

ASMBN/A

CAPRN/A

P/S Ratio

ASMB6.23x

CAPR23.36x

EV/Sales

ASMB5.80x

CAPR22.42x

EV/EBITDA

ASMB0.00x

CAPR1,019.20x

P/B Ratio

ASMB1.50x

CAPR2.11x

P/FCF Ratio

ASMBN/A

CAPRN/A

EV/FCF

ASMB-11.26x

CAPR-3.33x

PEG Ratio

ASMBN/A

CAPRN/A

Forward P/E (NTM)

ASMBN/A

CAPRN/A

Forward P/S (NTM)

ASMB17.93x

CAPR6.84x

Revenue (TTM)

ASMB$75M

CAPR$0

Revenue Growth (YoY)

ASMB125.1%

CAPR-100.0%

Forward Rev Growth

ASMB2.1%

CAPR-27.8%

Gross Margin (TTM)

ASMB0.0%

CAPR0.0%

Operating Margin (TTM)

ASMB0.0%

CAPR0.0%

EBITDA Margin (TTM)

ASMB-11.6%

CAPR0.0%

Net Margin (TTM)

ASMB-0.1%

CAPR0.0%

FCF Margin (TTM)

ASMB-51.5%

CAPRN/A

Net Income (TTM)

ASMB$-42K

CAPR$-129M

FCF (TTM)

ASMB$-39M

CAPR$-130M

EPS (TTM)

ASMB-$0.00

CAPR-$2.23

ROE (TTM)

ASMB-2.0%

CAPR-5660.0%

ROA (TTM)

ASMB-2.0%

CAPR-4397.0%

ROIC (TTM)

ASMB-2.0%

CAPR-5562.0%

Cash

ASMB$32M

CAPR$21M

Debt

ASMB$0

CAPR$0

Net Cash/Debt

ASMB$32M

CAPR$21M

Current Ratio (TTM)

ASMB13.99x

CAPR7.35x

Quick Ratio (TTM)

ASMB13.70x

CAPR7.22x

Debt/Equity (TTM)

ASMB0.00x

CAPR0.02x

Debt/Assets (TTM)

ASMB0.0%

CAPR0.0%

Interest Coverage (TTM)

ASMBN/A

CAPRN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

CAPR0.00x

Beta

ASMB1.21

CAPR0.59

52W Performance

ASMB-7.7%

CAPR4.4%

YTD Performance

ASMB-30.3%

CAPR-72.3%

% from 52W High

ASMB-40.7%

CAPR-80.6%

% from 52W Low

ASMB8.0%

CAPR164.5%

Asset Turnover (TTM)

ASMB0.28x

CAPR0.25x

FCF Yield (TTM)

ASMB-8.3%

CAPR-28.6%

Earnings Yield (TTM)

ASMB-0.0%

CAPR-28.5%

Dividend Yield (TTM)

ASMBN/A

CAPRN/A

Rule of 40

ASMB73.6

CAPR-100.0

EV/GP/RG

ASMBN/A

CAPRN/A

Ticker research

View ASMB research View CAPR research

Metric	ASMB Assembly Biosciences Inc	CAPR Capricor Therapeutics Inc
Market & Valuation
Market Cap	$466M	$453M
Enterprise Value	$434M	$433M
Price	$23.53	$7.83
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	23.36x
EV/Sales	5.80x	22.42x
EV/EBITDA	0.00x	1,019.20x
P/B Ratio	1.50x	2.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-3.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	6.84x
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	-100.0%
Forward Rev Growth	2.1%	-27.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-129M
FCF (TTM)	$-39M	$-130M
EPS (TTM)	-$0.00	-$2.23
ROE (TTM)	-2.0%	-5660.0%
ROA (TTM)	-2.0%	-4397.0%
ROIC (TTM)	-2.0%	-5562.0%
Financial Health
Cash	$32M	$21M
Debt	$0	$0
Net Cash/Debt	$32M	$21M
Current Ratio (TTM)	13.99x	7.35x
Quick Ratio (TTM)	13.70x	7.22x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.59
52W Performance	-7.7%	4.4%
YTD Performance	-30.3%	-72.3%
% from 52W High	-40.7%	-80.6%
% from 52W Low	8.0%	164.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.25x
FCF Yield (TTM)	-8.3%	-28.6%
Earnings Yield (TTM)	-0.0%	-28.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View CAPR research